Michiie Sakamoto mostly deals with Hepatocellular carcinoma, Pathology, Cancer research, Internal medicine and Carcinoma. His Hepatocellular carcinoma research is multidisciplinary, relying on both Tumor size, Cancer, Cirrhosis, Hepatitis and Radiology. His research in Pathology is mostly concerned with Immunohistochemistry.
His biological study spans a wide range of topics, including Cell culture, Gene expression, DNA methylation and Loss of heterozygosity. Michiie Sakamoto combines subjects such as Gastroenterology and Oncology with his study of Internal medicine. The Carcinoma study combines topics in areas such as Lipiodol, Endocrinology, Early Hepatocellular Carcinoma and Histopathology.
The scientist’s investigation covers issues in Pathology, Hepatocellular carcinoma, Internal medicine, Cancer research and Gastroenterology. Michiie Sakamoto studies Pathology, focusing on Immunohistochemistry in particular. His work in Hepatocellular carcinoma tackles topics such as Carcinoma which are related to areas like Biopsy.
His Internal medicine study integrates concerns from other disciplines, such as Hepatectomy, Oncology and Endocrinology. As part of one scientific family, Michiie Sakamoto deals mainly with the area of Cancer research, narrowing it down to issues related to the DNA methylation, and often Methylation. His Gastroenterology research integrates issues from Fibrosis and Surgery.
Michiie Sakamoto mainly focuses on Hepatocellular carcinoma, Internal medicine, Pathology, Gastroenterology and Cancer research. Michiie Sakamoto interconnects Resection, Carcinoma and Propensity score matching in the investigation of issues within Hepatocellular carcinoma. His study looks at the intersection of Internal medicine and topics like Oncology with Disease.
His Pathology study combines topics in areas such as Cancer cell and Stem cell. His Cancer research study also includes fields such as
Michiie Sakamoto spends much of his time researching Internal medicine, Hepatocellular carcinoma, Gastroenterology, Carcinoma and Pathology. As a part of the same scientific family, he mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Intrahepatic Cholangiocarcinoma, Cohort study and Local Ablation Therapy. His research in Hepatocellular carcinoma intersects with topics in Retrospective cohort study, Radiofrequency ablation, Propensity score matching, Hepatectomy and Survival analysis.
His work deals with themes such as Stage, Surgery, Liver cancer, Fibrosis and Receiver operating characteristic, which intersect with Gastroenterology. His work focuses on many connections between Pathology and other disciplines, such as Cancer cell, that overlap with his field of interest in Adenocarcinoma, Immunohistochemistry, Epithelial–mesenchymal transition and Gene knockdown. His research investigates the connection between Tumor microenvironment and topics such as Carcinogenesis that intersect with issues in Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.
Tadatoshi Takayama;Teruaki Sekine;Masatoshi Makuuchi;Susumu Yamasaki.
The Lancet (2000)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo;Namiki Izumi;Norihiro Kokudo;Osamu Matsui.
Digestive Diseases (2011)
Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia
Masamichi Kojiro;Ian R. Wanless;Venancio Alves;Sunil Badve.
Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.
Michiie Sakamoto;Setsuo Hirohashi;Yukio Shimosato.
Human Pathology (1991)
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.
T Takayama;T Kosuge;S Yamazaki;H Hasegawa.
The Lancet (1990)
β-Catenin Mutation in Carcinoma of the Uterine Endometrium
Takeshi Fukuchi;Michiie Sakamoto;Hitoshi Tsuda;Keiji Maruyama.
Cancer Research (1998)
Early hepatocellular carcinoma as an entity with a high rate of surgical cure
Tadatoshi Takayama;Masatoshi Makuuchi;Setsuo Hirohashi;Michiie Sakamoto.
Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases
Kei Yuki;Setsuo Hirohashi;Michiie Sakamoto;Toshio Kanai.
Increased Formation of Oxidative DNA Damage, 8-Hydroxydeoxyguanosine, in Human Livers with Chronic Hepatitis
Ryuya Shimoda;Makoto Nagashima;Michiie Sakamoto;Naohito Yamaguchi.
Cancer Research (1994)
Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma☆
Makoto Chuma;Makoto Chuma;Michiie Sakamoto;Ken Yamazaki;Tsutomu Ohta.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: